Status:

COMPLETED

Impact of Self-tonometry on Glaucoma Treatment Decision.

Lead Sponsor:

St. Erik Eye Hospital

Conditions:

Glaucoma

Glaucoma, Open-Angle

Eligibility:

All Genders

18+ years

Brief Summary

Self-tonometry with iCare Home is performed by one hundred patients annually at Sankt Erik's Eye Hospital. The investigators want to evaluate the impact that self-tonometry results have on the clinici...

Detailed Description

Since a few years back, self-tonometry has been available in glaucoma care. Self-tonometry allows patients to measure their eye pressure themselves using a portable tonometer. Sankt Erik's Eye Hospita...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • Diagnosed with POAG (primary open-angle glaucoma), PEX (pseudo-exfoliation glaucoma) or OHT (ocular hypertension)
  • Difference between patients' and staff's iCare Home® measurements less than 5 mmHg at Baseline
  • Difference between Goldman Applanation tonometry (GAT) and patient's highest iCare Home® measurements less than 7 mmHg at baseline
  • Monitoring over at least two days

Exclusion

  • More than one measurement with iCare Home® tonometer below 5 mmHg
  • Missing more than one daily measurement with iCare Home® tonometer

Key Trial Info

Start Date :

May 10 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 1 2022

Estimated Enrollment :

133 Patients enrolled

Trial Details

Trial ID

NCT04888156

Start Date

May 10 2021

End Date

February 1 2022

Last Update

March 16 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St Erik Eye Hospital

Stockholm, Sweden, 11282

Impact of Self-tonometry on Glaucoma Treatment Decision. | DecenTrialz